Modern Diagnostic IPO Subscription Status
Modern Diagnostic IPO was subscribed over 30.87x on its Second day till 05.00 PM on 1st January 2026.
- Modern Diagnostic IPO subscription QIB investors’ portion is 8.94x times, while NII subscribed 53.22x times, and RII investors subscribed 33.85x times.
- The company has received bids for 8,43,02,400 shares against 27,31,200 shares on offer on the Second day.
- Modern Diagnostic IPO was subscribed over 30.87x times on day 1.
- Modern Diagnostic IPO was subscribed over 5.60x times on day 1.
About the Modern Diagnostic IPO
Modern Diagnostic & Research Centre Limited, founded in 1985, is one of the leading diagnostic and healthcare-related services providers in India. The company offers a complete range of diagnostic facilities in radiology and pathology. Modern Diagnostic is involved in providing healthcare tests and services for diagnosis for individual patients, hospitals, healthcare providers, and corporate clients.
The company offers many diagnostic services in radiology and pathology, such as ultrasound and colour doppler, CT scan, MRI, digital X-ray, mammography, heart lab, neuro lab, laboratory tests, ECG, CBCT, OPG, PFT, and more. They also provide services like home sample collection, where they visit the patients to take the blood sample who are unable to visit the centre. Moreover, the company currently runs 21 centers, 17 labs, and 4 diagnostic centers across 8 states.
Modern Diagnostic IPO GMP
Modern Diagnostic IPO GMP was ₹13 as of Thursday, 1st January. That indicates the IPO is trading at ₹103 with a ₹13 premium in the grey market against the issue price of ₹90.
